Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C

MLA

Hirotaka Hirano, et al. “Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C.” Hepatitis Monthly, vol. 15, Feb. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....809d345992159366ed94c9dc9386d36a&authtype=sso&custid=ns315887.

APA

Hirotaka Hirano, Takeshi Azuma, Masaru Yoshida, Yoshihiko Yano, Kenji Momose, & Masaya Saito. (2015). Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepatitis Monthly, 15.

Chicago

Hirotaka Hirano, Takeshi Azuma, Masaru Yoshida, Yoshihiko Yano, Kenji Momose, and Masaya Saito. 2015. “Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C.” Hepatitis Monthly 15 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....809d345992159366ed94c9dc9386d36a&authtype=sso&custid=ns315887.